govt.fyi
Back to SB 1822
Oklahoma Legislature· SB 1822Second Reading referred to Business and Insurance

An act relating to medical marijuana licenses, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Oklahoma Legislature, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
1                               STATE OF OKLAHOMA

1

2                  2nd Session of the 60th Legislature (2026)

2

3 SENATE BILL 1822              By: Jett
3

4

4

5

5

6                               AS INTRODUCED

6

7   An Act relating to medical marijuana licenses;

7   authorizing certain research license; establishing

8   certain license purpose; providing certain

8   eligibility; requiring promulgation of certain rules;

9   establishing certain fees; providing for

9   codification; and providing an effective date.

10

10

11

11

12 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12

13  SECTION 1.         NEW LAW  A new section of law to be codified

13

14 in the Oklahoma Statutes as Section 427.19a of Title 63, unless
14

15 there is created a duplication in numbering, reads as follows:
15

16  A. The Oklahoma Medical Marijuana Authority shall be authorized

16

17 to create a research license to facilitate the collection, analysis,
17

18 and monitoring of patient-reported outcomes related to the use of
18

19 medical marijuana.
19

20  B. Research licensees may evaluate medical marijuana products

20

21 available in this state to analyze patient-reported outcomes.
21

22 Licensees may allow eligible entities to conduct studies including,
22

23 but not limited to, surveys and data collection to analyze the
23

24 impact of medical marijuana on medical conditions.
24

    Req. No. 3520                                              Page 1
1   C. Entities eligible for a license pursuant to this section

1

2 shall be:
2

3   1. Research institutions;

3

4   2. Health care organizations;

4

5   3. Licensed cannabis businesses; and

5

6   4. Private research companies.

6

7   D. The initial, nonrefundable fee for a patient-reported

7

8 outcome research license shall be Five Hundred Dollars ($500.00).
8

9   E. The Authority shall promulgate rules related to the issuance

9

10 of licenses, application approvals, compliance monitoring, and
10

11 reporting requirements.
11

12  SECTION 2. This act shall become effective November 1, 2026.

12

13

13

14  60-2-3520      BRC      1/14/2026 10:27:02 PM

14

15

15

16

16

17

17

18

18

19

19

20

20

21

21

22

22

23

23

24

24

    Req. No. 3520                                  Page 2
Every fact on this page links to its source, starting with the official bill record.